Advertisement

Poisonous Mushrooms

  • Gholamreza Karimi
  • Bibi Marjan Razavi
Reference work entry
Part of the Toxinology book series (TOXI, volume 2)

Abstract

Mushrooms are the sexual organs or fruiting bodies of fungi. Although some mushrooms are considered to be a rich source for nutrients and biologically active compounds, some species are known because of their toxicity that may cause fatalities every year generally due to misidentification. Among thousands of mushroom species, fewer than a hundred are toxic. Mushroom poisoning is associated with different signs and symptoms that are mainly attributed to some active substances belonging to poisonous mushrooms. Most mushroom toxins cause mild or moderate signs and symptoms such as nausea, vomiting, abdominal pain, fever, and headache. However, some species result in severe poisoning. Renal failure, neurotoxicity, hepatotoxicity, rhabdomyolysis, and other toxic effects were identified in toxicity studies with various species.

The toxicity of mushroom is influenced by many factors including genus and species, geographic location, preparation prior to ingestion, and the human’s susceptibility. This chapter is aimed to address various types of mushroom toxins, thus providing some information about their toxic mechanisms, a brief description of the toxicokinetics (absorption, distribution, metabolism, excretion) of mushroom toxins, and management of mushroom poisonings.

Keywords

Activate Charcoal Mushroom Species Ibotenic Acid Thioctic Acid Severe Poisoning 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Barbato M. Poisoning from accidental ingestion of mushrooms. Med J Aust. 1993;158:842–7.PubMedGoogle Scholar
  2. Bedry R, Baudrimont I, Defieux G, Creppy E, Pomies J, Dupon M, et al. Wild mushroom intoxication as a cause of rhabdomyolysis. N Engl J Med. 2001;345:798–802.PubMedCrossRefGoogle Scholar
  3. Berger K, Guss D. Mycotoxins revisited: part II. J Emerg Med. 2005;28:175–83.PubMedCrossRefGoogle Scholar
  4. Beuhler M, Graeme K. Overview of mushroom poisoning. In: Brent J, Wallace K, Burkhart K, Phillips S, Donovan, editors. Critical care toxicology. Mosby: Elsevier; 2005. p. 1263–75.Google Scholar
  5. Blayney D, Rosenkranz E, Zettner A. Mushroom poisoning from Chlorophyllum molybdites. West J Med. 1980;132:74–7.PubMedCentralPubMedGoogle Scholar
  6. Braun R, Greeff U, Netter K. Liver injury by the false morel poison gyromitrin. Toxicology. 1979;12:155–63.PubMedCrossRefGoogle Scholar
  7. Brent J, Palmer R. Mushrooms. In: Shnnon M, Borron S, Burns M, editors. Haddad and Winchester clinical management of poisoning and drug overdose. 4th ed. Philadelphia: Saunders Elsevier; 2007. p. 455–72.CrossRefGoogle Scholar
  8. Brooks E, Graeme K. Gyromitra mushrooms. In: Brent J, Wallace K, Burkhart K, Phillips S, Donovan, editors. Critical care toxicology. Mosby: Elsevier; 2005. p. 1287–94.Google Scholar
  9. Carlsson A, Henning M, Lindberg P, Martinson P, Trolin G, Waldeck B, et al. On the disulfiram-like effect of coprine, the pharmacologically active principle of Coprinus atramentarius. Acta Pharmacol Toxicol. 1978;42:292–7.CrossRefGoogle Scholar
  10. Danel V, Saviu P, Garon D. Main features of Cortinarius spp. poisoning: a literature review. Toxicon. 2001;39:1053–60.PubMedCrossRefGoogle Scholar
  11. De Haro L, Prost N, David J, Arditti J, Valli M. Syndrome sudorien et muscarinien. Experience de Centre Antipoisons de Marseille. Presse Med. 1999;28:1069e70.Google Scholar
  12. Donnelly M, Wax P. Cyclopeptide-containing mushrooms: deadly Amanita mushrooms. In: Brent J, Wallace K, Burkhart K, Phillips S, Donovan, editors. Critical care toxicology. Mosby: Elsevier; 2005. p. 1277–85.Google Scholar
  13. Enjalbert F, Rapior S, Nouguier-Soulé J, et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40:715–57.PubMedCrossRefGoogle Scholar
  14. French A, Garrettson L. Poisoning with the North American Jack O’Lantern mushroom, Omphalotus illudens. J Toxicol Clin Toxicol. 1988;26:81–8.PubMedCrossRefGoogle Scholar
  15. Gannett P, Garrett C, Lawson T, et al. Chemical oxidation and metabolism of N-methyl-N-formylhydrazine. Evidence for diazenium and radical intermediates. Food Chem Toxicol. 1991;29:49–56.PubMedCrossRefGoogle Scholar
  16. Goldfrank L. Mushrooms. In: Goldfrank L, editor. Goldfranks toxicology emergencies. New York: MC Graw-Hill; 2009. p. 1522–36.Google Scholar
  17. Hasler F, Bourquin D, Brenneisen R. Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. J Pharm Biomed Anal. 2002;30:331–9.PubMedCrossRefGoogle Scholar
  18. Jaeger A, Jehl F, Flesch F, et al. Kinetics of amatoxins in human poisoning: therapeutic implications. J Toxicol Clin Toxicol. 1993;31:63–80.PubMedCrossRefGoogle Scholar
  19. Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. “Silymarin”, a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci. 2010;14:308–17.Google Scholar
  20. Karlson-Stiber C, Persson H. Cytotoxic fungi – an overview. Toxicon. 2003;42:339–49.PubMedCrossRefGoogle Scholar
  21. Leist M, Gantner F, Naumann H, et al. Tumor necrosis factor induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology. 1997;112:923–34.PubMedCrossRefGoogle Scholar
  22. Lheureux P, Penaloza A, Gris M. Pyridoxine in clinical toxicology: a review. Eur J Emerg Med. 2005;12:78–85.PubMedCrossRefGoogle Scholar
  23. Lima ADL, Costa Fortes R, Garbi Novaes MRC, Percário S. Poisonous mushrooms; a review of the most common intoxications. Nutr Hosp. 2012;27:402–8.PubMedGoogle Scholar
  24. Lindell T, Weinberg F, Morris P, et al. Specific inhibition of nuclear RNA polymerase II by alpha-amanitin. Science. 1970;170:447–9.PubMedCrossRefGoogle Scholar
  25. Mas A. Mushrooms, amatoxins and the liver. J Hepatol. 2005;42:166–9.PubMedCrossRefGoogle Scholar
  26. Mayer K, Myers R, Lee S. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat. 2005;12:559–67.PubMedCrossRefGoogle Scholar
  27. Michelot D. Poisoning by Coprinus atramentarius. Nat Toxins. 1992;1:73–80.PubMedCrossRefGoogle Scholar
  28. Michelot D, Melendez-Howell L. Amanita muscaria: chemistry, biology and ethnomycology. Mycol Res. 2003;107:131–46.PubMedCrossRefGoogle Scholar
  29. Michelot D, Tebbett I. Poisoning by members of the genus Cortinarius – a review. Mycol Res. 1990;94:289–98.CrossRefGoogle Scholar
  30. Michelot D, Toth B. Gyromitra esculenta – a review. J Appl Toxicol. 1991;11:235–43.PubMedCrossRefGoogle Scholar
  31. Musshoff F, Madea B, Beike J. Hallucinogenic mushrooms on the German market – simple instructions for examination and identification. Forensic Sci Int. 2000;13:389–95.CrossRefGoogle Scholar
  32. Nielsen E, Schousboe A, Hansen S. Excitatory amino acids: studies on the biochemical and chemical stability of ibotenic acid and related compounds. J Neurochem. 1985;45:725–31.PubMedCrossRefGoogle Scholar
  33. Nilson A, Nystrom J, Buvall L, Ebefors K, Bjornson-Granqvist A, Holmdahl J, et al. The fungal nephrotoxin Orellanine simultaneously increases oxidative stress and down-regulates cellular defenses. Free Radic Biol Med. 2008;44:1562–9.CrossRefGoogle Scholar
  34. Salhab S. A minireview on mushroom: emphasis on the wild mushroom of Jordan. Jordan Med J. 2007;41:170–8.Google Scholar
  35. Santi L, Maggioli C, Mastroroberto M, Tufoni M, Napoli L, Caraceni P. Acute liver failure caused by Amanita phalloides. Int J Hepatol. 2012;2012:487480.PubMedCentralPubMedGoogle Scholar
  36. Stallard D, Edes T. Muscarinic poisoning from medications and mushrooms. A puzzling symptom complex. Postgrad Med. 1989;85:341–5.PubMedGoogle Scholar
  37. Stormer F, Koller G, Janak K. Ibotenic acid in Amanita muscaria spores and caps. Mycologist. 2004;18:114–7.CrossRefGoogle Scholar
  38. Tegzes J, Puschner B. Toxic mushrooms. Vet Clin Small Anim. 2002;32:397–407.CrossRefGoogle Scholar
  39. Toth B, Gannett P. Gyromitra esculenta mushroom: a comparative assessment of its carcinogenic potency. In Vitro. 1994;8:999–1002.Google Scholar
  40. Tsujikawa K, Mohri H, Kuwayama K, Miyaguchi H, Iwata Y, Gohda A, et al. Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan. Forensic Sci Int. 2006;164:172–8.PubMedCrossRefGoogle Scholar
  41. Tsujikawa K, Kuwayama K, Kanamori T, Iwata Y, Inoue H, Yoshida T, et al. Determination of muscimol and ibotenic acid in Amanita mushrooms by high-performance liquid chromatography and liquid-chromatography-tandem mass spectrometry. J Chromatogr. 2007;852:430–5.Google Scholar
  42. Venkataramanan R, Ramachandran V, Komoroski B, et al. Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metab Dispos. 2000;28:1270–3.PubMedGoogle Scholar
  43. Villar D, Knight M, Holding J, et al. Treatment of acute isoniazid overdose in dogs. Vet Hum Toxicol. 1995;37:473–7.PubMedGoogle Scholar
  44. Vogel G, Tuchweber B, Trost W, et al. Protection by silibinin against Amanita phalloides intoxication in beagles. Toxicol Appl Pharmacol. 1984;73:355–62.PubMedCrossRefGoogle Scholar
  45. Ward J, Kapadia K, Brush E, Salhanick S. Amatoxin poisoning: case reports and review of current therapies. J Emerg Med. 2013;44:116–21.PubMedCrossRefGoogle Scholar
  46. West P, Lindgren J, Horowitz B. Amanita smithiana mushroom ingestion: a case of delayed renal failure and literature review. J Med Toxicol. 2009;5:32–8.PubMedCentralPubMedCrossRefGoogle Scholar
  47. Wieland T. The toxic peptides from Amanita mushrooms. Int J Pept Protein Res. 1983;22:257–76.PubMedCrossRefGoogle Scholar
  48. Young A. Muscarine-containing mushrooms. In: Spoerke D, Rumack B, editors. Handbook of mushroom poisoning – diagnosis and treatment. Boca Raton: CRC Press; 1994. p. 399–418.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  1. 1.Medical Toxicology Research Center and Pharmacy SchoolMashhad University of Medical SciencesMashhadIran
  2. 2.Department of Pharmacodynamy and ToxicologyMashhad University of Medical SciencesMashhadIran

Personalised recommendations